Dale, D. C., Bolyard, A. A., Kelley, M. L., Westrup, E. C., Makaryan, V., Aprikyan, A., . . . Hsu, F. J. (2011). The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. American Society of Hematology.

Dale, David C., Audrey Anna Bolyard, Merideth L. Kelley, Ernest C. Westrup, Vahagn Makaryan, Andrew Aprikyan, Brent Wood, e Frank J. Hsu. The CXCR4 Antagonist Plerixafor Is a Potential Therapy for Myelokathexis, WHIM Syndrome. American Society of Hematology, 2011.

Dale, David C., et al. The CXCR4 Antagonist Plerixafor Is a Potential Therapy for Myelokathexis, WHIM Syndrome. American Society of Hematology, 2011.